SecBot SecBot
SC 13G/A ·Filed Nov 16, 2026

TMCI

TREACE MEDICAL CONCEPTS, INC.
BEARISH
Impact 4/10
Horizonweeks Processed1d 9h ago SEC0001172661-26-005257
Passive stake amendment
Actionable Insight ▼ Bearish

Monitor for further insider or institutional selling. Armistice Capital's exit below 5% removes a passive holder that previously held a meaningful position, potentially reducing support for the stock.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$4.42
T+0 close · Nov 16, 2026 · via day close
Latest settled
+0.45%
T+1 · $4.44
Vs SPY
+1.47%
α at T+1
Next horizon
T+5
in 5d
  1. T+0 · Nov 16 $4.42entry
  2. T+1 · 15h ago +0.45%α +1.47% · $4.44
  3. T+5 · in 5d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Armistice Capital filed an amended Schedule 13G disclosing a 1.96% passive stake in Treace Medical Concepts as of September 30, 2026, down from a prior 5%+ position. The reduction below the 5% threshold signals a significant exit by a former top holder.

Key Financial Metrics

Stake
1.96%
Investor
Armistice Capital, LLC
Investor Type
hedge fund

Key Facts

  • Armistice Capital reported beneficial ownership of 6,364,000 shares of Treace Medical Concepts common stock as of September 30, 2026.
  • The stake represents 1.96% of shares outstanding, down from a prior 5%+ position disclosed in May 2026.
  • Armistice Capital is a passive filer under Rule 13d-1(b) and disclaims control intent.
  • Steven Boyd, managing member of Armistice Capital, is also reported as a beneficial owner of the same shares.

Financial Impact

Armistice Capital reduced its stake from above 5% to 1.96%, representing a reduction of over 3 percentage points of ownership.

ownership concentration

Risk Factors

  • Loss of a significant institutional holder may signal reduced confidence in the company's outlook.
  • The company's Q3 2026 revenue declined 4% YoY, and the stock has weak analyst consensus (5 Hold, 2 Sell, 2 Strong Sell).

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
10% bullish (10 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001172661-26-005257
Document: 0001172661-26-005257-index.html0001172661-26-005257
Document: 0001172661-26-005257.txt0001172661-26-005257

Track record

11 reports on TMCI

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 20261d ago SC 13G Neutral 4/10 Entry $4.42 to $4.44 Now $4.44 +0.45% ▲ +0.45% +1.47% vs SPY
  2. Nov 16, 20261d ago SC 13G/A Bearish 4/10 Viewing Entry $4.42 to $4.44 Now $4.44 −0.45% ▼ −0.45% −1.47% vs SPY
  3. Nov 12, 20266d ago Court Ruling Neutral 4/10 Entry $5.27 to $4.42 Now $4.44 −15.75% ▼ −16.13% −14.22% vs SPY
  4. Nov 6, 202611d ago 8-K Neutral 4/10 Entry $4.03 to $4.78 Now $4.44 +10.17% ▲ +18.61% +16.24% vs SPY
  5. Sep 17, 20268w ago Press Release Neutral 4/10 Entry $4.49 to $4.48 Now $4.44 −1.11% ▼ −0.22% −1.77% vs SPY
  6. Aug 7, 202614w ago 8-K Mixed 6/10 Entry $4.76 to $4.67 Now $4.44 −6.72% ▼ −1.89% −1.86% vs SPY
  7. Jul 13, 202618w ago Court Ruling Bearish 5/10 Entry $4.44 to $4.40 Now $4.44 −0.00% ▲ +0.90% +1.30% vs SPY
  8. May 8, 202627w ago Press Release Bearish 7/10 Entry $2.01 to $1.94 Now $4.44 −120.90% ▲ +3.48% +3.71% vs SPY
  9. Apr 24, 202629w ago Press Release Neutral 1/10 Entry $1.98 to $1.92 Now $4.44 +124.24% ▼ −3.03% −3.19% vs SPY
  10. Apr 9, 202631w ago 8-K Mixed 6/10 Entry $1.53 to $1.81 Now $4.44 +190.20% ▲ +18.30% +18.36% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Thu (11h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026